Origin Pharma Packaging Invest in New Clean Room Manufacturing – Enhancing the HP3 Network
As legislation and ethical awareness evolves, Origin Pharma Packaging has seen the demand for innovative design and production of child safe packaging increase on a global scale.
Our new product development (NPD) team are continually investing their time and knowledge developing commercial solutions for child resistant compliant packaging for the UK, Europe, the U.S.A and beyond.
During the past twenty-four months, Origin Pharma Packaging have partnered custom design and manufacturing projects not compatible with the larger manufacturing sites across the HP3 (Hybrid Pharma Packaging) network. As a result, Origin have added a new clean room manufacturing facility to HP3 network, located in Melton, East Yorkshire, UK.
Origin have executed a multi-million-pound investment programme at our Centre of Excellence for Pharmaceutical Packaging Design & Innovation. Installing and delivering a clean room production facility to ISO 7 (class 10,000) or ISO8 (class 100,000) boosting the capabilities of the existing HP3 network. The facility is equipped for the manufacture of Injection Moulded (IM), Injection Stretch Blow Moulded (ISBM) and Injection Blow Moulded (IBM) parts.
Clean room production facility key facts:
Classification: ISO7/ class 10,000 to ISO8/ class 100,000
Compliant to ISO14644 | ISO9001 – ISO 15378 | BRC
Processes (all-electric):
Injection Moulding (IM)
Injection Stretch Blow Moulding (ISBM)
Injection Blow Moulding (IBM)
Automatic Assembly
The HP3 network required the addition of this specific facility at a regional level – combining cleanroom classification, multiple ISO and GMP compliance, MHRA pursuit, EUPh compliant raw material sources, custom flexibility and integral supply chain assurance.
Due to the urgency of a sponsor project – a global pharmaceuticals manufacturing company – Origin executed and delivered the clean room production facility within four months. It is now fully functional, and production commenced in Q1 2018.
Watch the transition of the space into a pharmaceutical, clean room manufacturing facility here:
If you would like to receive more information on the clean room manufacturing facility or you have an enquiry regarding a new project, please get head to our new dedicated area on our website: https://originltd.com/cleanroom-manufacturing/
Related Posts
VIEW ALL Posts
PPWR: What the New EU Packaging Regulations Mean for Businesses Selling into Europe
The Packaging and Packaging Waste Regulation (PPWR) is one of the most significant pieces of packaging legislation introduced by the European Union in recent years. From 12 August 2026, new requirements will begin to apply to packaging placed on the EU and EU associated market countries, with further measures being introduced gradually through to 2040…
Child-Resistant Packaging: Balancing Child Safety with Senior Accessibility
With many varieties of pharmaceutical packaging and lifestyle product packaging, there’s a need for child-resistant packaging for the safety of end users and to meet industry regulations. However, the design of child-resistant packaging presents a challenge. It must be difficult for children to open, but accessible enough for adults. However, this can present challenges with…
Why Child-Resistant Vape Packaging is a Non-Negotiable
As the vape industry continues to grow, the need for dependable packaging that bears the needs of its users in mind becomes increasingly important. Specifically, packaging that prevents the risk of harm to children through unintended use of vape products is imperative. To meet this need, using child-resistant packaging is not only an ethical responsibility…
